Does heterozygous beta-thalassemia confer a protection against coronary artery disease?

Ann N Y Acad Sci. 2005:1054:467-70. doi: 10.1196/annals.1345.068.

Abstract

Six hundred and thirty-eight patients who presented with clinical symptoms and/or electrocardiographic findings suggestive of stable angina pectoris were studied; they were also investigated by coronary arteriography. Hemoglobin electrophoresis was performed on all patients to detect the presence of the beta-thalassemia trait. Results were analyzed by logistic regression analysis to determine whether the latter confers any protective effect against advanced coronary artery disease (aCAD; defined as the presence of atheromas in coronary arteries, resulting in stenosis at least 70%). The role of the currently accepted risk factors (smoking, hypertension, hypercholesterolemia, and diabetes) in developing aCAD were reconfirmed, while at the same time it was found that beta-thalassemia heterozygosity is associated with a reduced risk against aCAD (odds ratio 0.39, 95% confidence interval 0.16-0.98). The lipoprotein and blood rheology profile of these individuals may be the underlying causes of this protective effect.

MeSH terms

  • Aged
  • Angina Pectoris / diagnostic imaging
  • Angina Pectoris / epidemiology
  • Angina Pectoris / genetics
  • Blood Protein Electrophoresis
  • Comorbidity
  • Coronary Angiography
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / epidemiology*
  • Coronary Disease / genetics
  • Diabetes Mellitus / epidemiology
  • Female
  • Greece / epidemiology
  • Hemoglobins / analysis
  • Hemoglobins / genetics
  • Hemorheology
  • Heterozygote
  • Humans
  • Hyperlipidemias / epidemiology
  • Hypertension / epidemiology
  • Male
  • Middle Aged
  • Odds Ratio
  • Risk Factors
  • Smoking / epidemiology
  • beta-Thalassemia / epidemiology*
  • beta-Thalassemia / genetics

Substances

  • Hemoglobins